Connection

Mark Lewis to Vaccination

This is a "connection" page, showing publications Mark Lewis has written about Vaccination.
Connection Strength

0.076
  1. mRNA-1273 protects against SARS-CoV-2 beta infection in nonhuman primates. Nat Immunol. 2021 10; 22(10):1306-1315.
    View in: PubMed
    Score: 0.009
  2. Protective antibodies elicited by SARS-CoV-2 spike protein vaccination are boosted in the lung after challenge in nonhuman primates. Sci Transl Med. 2021 08 18; 13(607).
    View in: PubMed
    Score: 0.009
  3. Low-dose Ad26.COV2.S protection against SARS-CoV-2 challenge in rhesus macaques. Cell. 2021 06 24; 184(13):3467-3473.e11.
    View in: PubMed
    Score: 0.009
  4. Neutralizing antibody vaccine for pandemic and pre-emergent coronaviruses. Nature. 2021 06; 594(7864):553-559.
    View in: PubMed
    Score: 0.009
  5. Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques. Nature. 2020 10; 586(7830):583-588.
    View in: PubMed
    Score: 0.009
  6. DNA vaccine protection against SARS-CoV-2 in rhesus macaques. Science. 2020 08 14; 369(6505):806-811.
    View in: PubMed
    Score: 0.009
  7. Nucleoside-modified mRNA vaccines induce potent T follicular helper and germinal center B cell responses. J Exp Med. 2018 06 04; 215(6):1571-1588.
    View in: PubMed
    Score: 0.007
  8. Durability and correlates of vaccine protection against Zika virus in rhesus monkeys. Sci Transl Med. 2017 Dec 13; 9(420).
    View in: PubMed
    Score: 0.007
  9. Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination. Nature. 2017 03 09; 543(7644):248-251.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.